Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
To evaluate the efficacy of combining the dual endothelin receptor antagonist, bosentan, and the phosfodiesterase-5-inhibitor, sildenafil, in patients with Eisenmenger syndrome.
Originalsprog | Engelsk |
---|---|
Tidsskrift | European Heart Journal |
Vol/bind | 31 |
Udgave nummer | 9 |
Sider (fra-til) | 1124-31 |
Antal sider | 8 |
ISSN | 0195-668X |
DOI | |
Status | Udgivet - 1 maj 2010 |
ID: 34080333